BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2296657)

  • 21. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Enhanced MRI of breast cancer smaller than 3 cm].
    Ikeda Y; Narabayashi I; Yoshida S; Motohara T; Koizumi T; Ogawa K; Mieda C; Ueda E; Hirota S; Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Nov; 51(11):1314-23. PubMed ID: 1662800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
    Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
    Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
    Nunes LW; Schnall MD; Siegelman ES; Langlotz CP; Orel SG; Sullivan D; Muenz LA; Reynolds CA; Torosian MH
    AJR Am J Roentgenol; 1997 Aug; 169(2):409-15. PubMed ID: 9242744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral washout sign on contrast-enhanced MR images of the breast.
    Sherif H; Mahfouz AE; Oellinger H; Hadijuana J; Blohmer JU; Taupitz M; Felix R; Hamm B
    Radiology; 1997 Oct; 205(1):209-13. PubMed ID: 9314987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.
    Tien RD; Brasch RC; Jackson DE; Dillon WP
    Radiology; 1989 Sep; 172(3):791-2. PubMed ID: 2772189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR imaging of the breast after surgery for breast cancer.
    Whitehouse GH; Moore NR
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging with Gd-DTPA in lesions of the head and neck.
    Vogl Th; Dresel S; Juergens M; Assal J; Lissner J
    J Otolaryngol; 1993 Aug; 22(4):220-30. PubMed ID: 8230372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MR mammography in patients at risk].
    Kaiser WA; Mittelmeier O
    Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI.
    Mirowitz SA; Totty WG; Lee JK
    J Comput Assist Tomogr; 1992; 16(1):120-5. PubMed ID: 1729290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.